4basebio PLC (88Q.DE)

EUR 14.6

(0.0%)

Total Liabilities Summary of 4basebio PLC

  • 4basebio PLC's latest annual total liabilities in 2023 was 12.41 Million GBP , up 171.7% from previous year.
  • 4basebio PLC's latest quarterly total liabilities in 2023 FY was 12.41 Million GBP , up 171.7% from previous quarter.
  • 4basebio PLC reported annual total liabilities of 4.56 Million GBP in 2022, up 51.95% from previous year.
  • 4basebio PLC reported annual total liabilities of 3 Million GBP in 2021, up 27.9% from previous year.
  • 4basebio PLC reported quarterly total liabilities of 12.41 Million GBP for 2023 FY, up 171.7% from previous quarter.
  • 4basebio PLC reported quarterly total liabilities of 8.14 Million GBP for 2023 Q2, up 78.27% from previous quarter.

Annual Total Liabilities Chart of 4basebio PLC (2023 - 2019)

Historical Annual Total Liabilities of 4basebio PLC (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 12.41 Million GBP 171.7%
2022 4.56 Million GBP 51.95%
2021 3 Million GBP 27.9%
2020 2.35 Million GBP -22.79%
2019 3.04 Million GBP 0.0%

Peer Total Liabilities Comparison of 4basebio PLC

Name Total Liabilities Total Liabilities Difference
BioNTech SE 2.76 Billion EUR 99.55%
CureVac N.V. 271.53 Million EUR 95.428%
Biotest Aktiengesellschaft 945.4 Million EUR 98.687%
Biotest Aktiengesellschaft 945.4 Million EUR 98.687%
BRAIN Biotech AG 47.92 Million EUR 74.096%
Formycon AG 387.61 Million EUR 96.797%
Heidelberg Pharma AG 21.01 Million EUR 40.923%
Medigene AG 10.65 Million EUR -16.563%